What is Arboris?
Arboris, LLC is recognized globally as the premier producer of plant sterols, which are naturally occurring compounds known for their cholesterol-reducing properties. Sourced from pine trees, a renewable resource, Arboris' plant sterols are processed to achieve a 99% purity of naturally-occurring phytosterols, ensuring they are free from genetic modification. These high-standard ingredients are integral to a wide array of food products, including spreads, juices, bread, and dairy items, meeting the growing consumer demand for healthier food options. The company's commitment to purity and quality positions it as a key supplier in the functional food ingredients sector.
How much funding has Arboris raised?
Arboris has raised a total of $2.8M across 2 funding rounds:
Debt
$1M
Debt
$1.8M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.8M led by PPP
Key Investors in Arboris
PPP
Public-Private Partnership
PPP
Public-Private Partnership
Undisclosed Investor
An undisclosed investor has made a significant strategic investment in Arboris, indicating confidence in the company's market position and future growth potential.
What's next for Arboris?
The substantial enterprise-level capital infusion and recent strategic investment signal a strong growth phase for Arboris. This backing is expected to fuel further innovation in product development, enhance production capacity, and potentially expand Arboris' global footprint. The company's focus on sustainable sourcing and high-purity ingredients aligns with market trends favoring natural and health-conscious products. Arboris is strategically positioned to capitalize on the increasing demand for plant-based sterols in the food and beverage industry, likely exploring new applications and partnerships to solidify its market leadership.
See full Arboris company page
